Description: Navigate challenging mTBI cases with with Abbott's TBI plasma, an objective biomarker test for mild traumatic brain injury (mTBI).
Millions of patients undergo emergency department (ED) evaluation for mTBI each year. Neurocognitive assessments, such as the Glasgow Coma Scale (GCS) and clinical decision rules (CDRs), are subjective and can be difficult to perform with certain patients, such as those who are intoxicated or have an altered mental health status.¹
As a result, you may decide to order a CT, despite having low clinical suspicion of intracranial bleeding. In fact, while an estimated 82% of patients with TBI undergo CT, more than 90% show no evidence of traumatic abnormality .² What’s more, some patients may insist on a CT even though you deem it unwarranted.
The i-STAT TBI Plasma test may be the solution to provide objective data without time-consuming and often avoidable head CTs for mTBI.